Vousden Karen Hinsider trades

In SEC Form 4 filings, Vousden Karen H is listed as Director of Faeth Therapeutics, Inc. (FTH). Vousden Karen H reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 15.

Companies and roles

Company	Role	Transactions	Last filed
FTHFaeth Therapeutics, Inc.	Director	1	Sep 15

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-15

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
FTHFaeth Therapeutics, Inc.	Sep 11	Sep 15	A · derivative	25,000	$37.44	$936,000	25,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.